2021 Vault Rankings
At a Glance
“An amazing collection of humble, good-natured, exceptionally smart people.”
“Solving very interesting problems for our clients.”
“Promotion opportunities each of your first three years.”
“Double staffing can be a blessing and a curse.”
“The hours can be unmanageable at times.”
“Not international enough.”
“Top biopharma strategy firm.”
“Major healthcare competitor.”
“Strong life sciences focus; smart employees.”
About Putnam Associates
For more than 30 years Putnam Associates has grown into a premier strategy consulting firm serving biopharmaceutical, biotechnology (cell, gene and tissue therapies), diagnostics, medical device, and related clients in the healthcare space. The firm provides objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle. Putnam's clients range from venture-backed biotechs to Fortune 500 companies, including the majority of the world's major biopharmaceutical companies–indeed, despite being based in the US, more than half of Putnam's projects are global in focus. Putnam's commitment to client success has sustained many relationships that stretch back more than a decade and has enabled continued expansion into new client opportunities every year.
Putnam focuses solely on the life sciences, offering services focused on both development-stage and marketed products. That's good news for clients, who can spend more than 10 years developing new products-including wading through years of discovery, comprehensive testing, regulatory reviews, and commercialization prep-before the products even make it to market. Services fall into five main areas: Pricing and Market Access, New Product Development Strategy, Commercialized Product and Franchise Strategy, Portfolio and Business Development Strategy, and Enterprise Solutions.
Committed to Long-Term Relationships
By providing insight and long-term support, Putnam has become the strategic partner of choice to a growing roster of clients. That long-term commitment also goes for the firm's employees–rather than being a landing spot for a year or two, the firm wants employees to see the potential for a longer-term career at Putnam. The firm provides both formal and informal mentorship, and cultivates an enriching professional culture. Knowledge development projects delve into the latest breakthroughs in areas like cell, gene, and tissue therapy leading to exciting new clients. The firm promotes community engagement and personal growth. Putnam sponsors a Summer Days of Service initiative driven by staff where Putnam teams volunteer their time and energy to support Boston and San Francisco area community organizations.
When Putnam's consultants do leave, the firm is committed to fostering the professional success of alumni, recently launching a program of alumni outreach and events that bring together a growing roster of former staff that have gone on to success in other biotech pursuits.
Ensuring a Successful Launch
Nearly half of Putnam's projects in the past year have addressed the challenges of bringing cutting edge medical innovations to market. The firm is currently supporting clients on the cutting edge in CAR-T cancer therapies, gene therapies, and stem cell therapies. In a typical recent project, Putnam helped validate the epidemiology of untreated patient populations, then worked with the client to better define unmet medical needs in the therapeutic area. This led to recommendations around endpoints in Phase III trial designs. Putnam then worked with the commercial team to build strategies around introducing the product to target markets. At the same time, Putnam helped build forecast models for key countries and conducted pipeline assessments to help the client keep abreast of fast moving clinical developments among competitors (which also informed in-licensing scans). Whether Putnam's clients are honing their portfolios, developing new products, or trying to grow marketed products, the firm's strength lies in its ability to consistently deliver exceptional work and superior insights on the industry's complex challenges.
In the News
CAR-T Roundtable Discussion – 12/3/20
In 2019, Putnam formed a select panel of cell and gene therapy (CGT) experts to meet our clients’ growing demand for CGT strategy and commercialization support. By engaging with our expert panel, Putnam is at the leading edge of this rapidly evolving space, delivering to our CGT-focused clients unparalleled insight into clinical decision-making, product on-boarding and logistical challenges, emerging technologies, and key market trends.
In the lead-up to ASH, Putnam held our first CGT roundtable event with four leading experts from our panel. Joseph Feingold and Colleen Sadin, leaders of Putnam’s CGT practice, moderated the discussion on the current and future state of CAR-T cell therapy in oncology: “Three years of commercial CAR-T: Where are We and Where are we headed?”
The Boston Globe Names Putnam a Top Workplace – 11/24/20
Putnam Associates has been named one of the Top Places to Work in Massachusetts in the 13th annual employee-based survey project from The Boston Globe. The Top Places to Work 2020 issue publishes online at Globe.com/TopPlaces on the night of November 19 and in Globe Magazine on November 22. Top Places to Work recognizes the most admired workplaces in the state voted on by the people who know them best—their employees. The survey measures employee opinions about their company’s direction, execution, connection, management, work, pay and benefits, and engagement. The employers are placed into one of four groups: small, with 50 to 99 employees; medium, with 100 to 249 workers; large, with 250 to 999; and largest, with 1,000 or more.
Putnam Associates was ranked 45th in the Medium Sized Companies category.
Putnam Announces Fall Promotions, Kristen Moffat to Partner – 11/23/20
We are thrilled to announce recent promotions throughout the firm including Yuanfei Wang to Principal; Mariah Hanley and Simran Madan to Senior Consultant; and Karyll Davis, Martha Gilchrist and Carri Hui Mingalone to Consultant.
We are also excited to announce the promotion of Kristen Moffat to Partner in our Boston office. Kristen embodies the core values we strive to achieve as a firm and we are thrilled to have her bold leadership added to our Partner team.
Putnam CEO Remco op den Kelder shared his thoughts on Kristen’s promotion,
“Becoming a partner at Putnam is not an easy feat. It requires providing consistent high level strategic insights and guidance to our clients; and from the day that Kristen arrived at Putnam, almost 7 years ago, she has done exactly that. Over the years, she has developed deep relationships with the clients she has worked with and is seen as a true strategic thought partner. We are a better firm by having Kristen on our team and we could not be prouder having her become a partner.”
Why Work Here
- At Putnam, we operate with a team-based approach that is client focused and impact oriented.
- Putnam is a specialist firm where employees are given the opportunity to excel.
- Putnam relies on the talent and motivation of our staff.
- Putnam Associates has built a close-knit and supportive culture.
501 Boylston Street
Boston, MA 02116
Phone: (617) 456-5200
Employer Type: Private
CEO: Remco op den Kelder
Employees (All Locations): 150
Boston, MA (HQ)
San Francisco, CA
New York, NY
Value, Pricing, & Access Strategy
New Product Development Strategy
Established Product and Franchise Strategy
Medical Affairs Strategy
Portfolio, Licensing & Development Strategy